title: The main target for inhibiting mineralocorticoid receptor-mediated signaling in cardiovascular diseases.
authors.affiliation: Division of Cardiovascular Medicine, Endocrinology and Metabolism, Department of Molecular Medicine and Therapeutics, Faculty of Medicine, Tottori University, Yonago, Japan. ykazuhiro@med.tottori-u.ac.jp
authors.forename: Kazuhiro
authors.initials: K
authors.lastname: Yamamoto
mesh_terms: D000818:Animals; D054732:Calcium-Calmodulin-Dependent Protein Kinase Type 2 / Q000037:antagonists & inhibitors / Q000502:physiology; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D006801:Humans; D000451:Mineralocorticoid Receptor Antagonists / Q000494:pharmacology*; D018161:Receptors, Mineralocorticoid / Q000502:physiology; D015398:Signal Transduction / Q000187:drug effects*
chemical_list: D000451:Mineralocorticoid Receptor Antagonists; D018161:Receptors, Mineralocorticoid; D054732:Calcium-Calmodulin-Dependent Protein Kinase Type 2